Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Correction to: Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.

Mathur S, O'Malley ME, Ghai S, Jhaveri K, Sreeharsha B, Margolis M, Zhong L, Maan H, Toi A.

Abdom Radiol (NY). 2019 Nov 22. doi: 10.1007/s00261-019-02330-7. [Epub ahead of print]

PMID:
31758228
2.

Detection of Relapse by Low-dose Computed Tomography During Surveillance in Stage I Testicular Germ Cell Tumours.

Chung P, O'Malley ME, Jewett MAS, Bedard PL, Panzarella T, Sturgeon J, Moore MJ, Hamilton R, Hansen AR, Anson-Cartwright L, Gospodarowicz M, Warde P.

Eur Urol Oncol. 2019 Jul;2(4):437-442. doi: 10.1016/j.euo.2018.08.031. Epub 2018 Oct 2.

PMID:
31277780
3.

Correlation of 3T multiparametric prostate MRI using prostate imaging reporting and data system (PIRADS) version 2 with biopsy as reference standard.

Mathur S, O'Malley ME, Ghai S, Jhaveri K, Sreeharsha B, Margolis M, Zhong L, Maan H, Toi A.

Abdom Radiol (NY). 2019 Jan;44(1):252-258. doi: 10.1007/s00261-018-1696-8. Erratum in: Abdom Radiol (NY). 2019 Nov 22;:.

PMID:
30032385
4.

Primary perivascular epithelioid cell tumors of the liver: CT/MRI findings and clinical outcomes.

O'Malley ME, Chawla TP, Lavelle LP, Cleary S, Fischer S.

Abdom Radiol (NY). 2017 Jun;42(6):1705-1712. doi: 10.1007/s00261-017-1074-y.

PMID:
28246920
5.

Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers.

Downs-Canner S, Guo ZS, Ravindranathan R, Breitbach CJ, O'Malley ME, Jones HL, Moon A, McCart JA, Shuai Y, Zeh HJ, Bartlett DL.

Mol Ther. 2016 Aug;24(8):1492-501. doi: 10.1038/mt.2016.101. Epub 2016 May 16.

6.

CT following US for possible appendicitis: anatomic coverage.

O'Malley ME, Alharbi F, Chawla TP, Moshonov H.

Eur Radiol. 2016 Feb;26(2):532-8. doi: 10.1007/s00330-015-3778-0. Epub 2015 Oct 31.

PMID:
26518583
7.

Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.

Downs-Canner S, Magge D, Ravindranathan R, O'Malley ME, Francis L, Liu Z, Sheng Guo Z, Obermajer N, Bartlett DL.

Ann Surg Oncol. 2016 Feb;23(2):655-62. doi: 10.1245/s10434-015-4778-7. Epub 2015 Aug 20.

8.

Canadian Association of Radiologists Radiation Protection Working Group: Automated Patient-Specific Dose Registries—What Are They and What Are They Good for?

Bjarnason TA, Thakur Y, Chakraborty S, Liu P, O'Malley ME, Coulden R, Noga M, Mason A, Mayo J.

Can Assoc Radiol J. 2015 Aug;66(3):192-7. doi: 10.1016/j.carj.2014.12.005. Epub 2015 Apr 17. Review.

9.

Assessment of feasibility of running RSNA's MIRC on a Raspberry Pi: a cost-effective solution for teaching files in radiology.

Pereira A, Atri M, Rogalla P, Huynh T, O'Malley ME.

Int J Comput Assist Radiol Surg. 2015 Nov;10(11):1793-801. doi: 10.1007/s11548-014-1143-4. Epub 2014 Dec 30.

PMID:
25547256
10.

First-in-man study of western reserve strain oncolytic vaccinia virus: safety, systemic spread, and antitumor activity.

Zeh HJ, Downs-Canner S, McCart JA, Guo ZS, Rao UN, Ramalingam L, Thorne SH, Jones HL, Kalinski P, Wieckowski E, O'Malley ME, Daneshmand M, Hu K, Bell JC, Hwang TH, Moon A, Breitbach CJ, Kirn DH, Bartlett DL.

Mol Ther. 2015 Jan;23(1):202-14. doi: 10.1038/mt.2014.194. Epub 2014 Oct 8.

11.

Inhibitors of C5 complement enhance vaccinia virus oncolysis.

Magge D, Guo ZS, O'Malley ME, Francis L, Ravindranathan R, Bartlett DL.

Cancer Gene Ther. 2013 Jun;20(6):342-50. doi: 10.1038/cgt.2013.26. Epub 2013 May 10.

12.

Imaging of abdominal complications associated with hematopoietic stem cell transplantation.

Vlachou PA, O'Malley ME.

Can Assoc Radiol J. 2014 Feb;65(1):35-41. doi: 10.1016/j.carj.2012.11.001. Epub 2013 Mar 28. Review.

13.

A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosis.

Thirunavukarasu P, Sathaiah M, Gorry MC, O'Malley ME, Ravindranathan R, Austin F, Thorne SH, Guo ZS, Bartlett DL.

Mol Ther. 2013 May;21(5):1024-33. doi: 10.1038/mt.2013.27. Epub 2013 Feb 26.

14.

Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT?

O'Malley ME, Tran P, Hanbidge A, Rogalla P.

AJR Am J Roentgenol. 2012 Dec;199(6):1312-5. doi: 10.2214/AJR.12.8616.

PMID:
23169723
15.

Mucin as a therapeutic target in pseudomyxoma peritonei.

Choudry HA, O'Malley ME, Guo ZS, Zeh HJ, Bartlett DL.

J Surg Oncol. 2012 Dec;106(7):911-7. doi: 10.1002/jso.23146. Epub 2012 May 14. Review.

PMID:
22585683
16.

Detection of urothelial tumors: comparison of urothelial phase with excretory phase CT urography--a prospective study.

Metser U, Goldstein MA, Chawla TP, Fleshner NE, Jacks LM, O'Malley ME.

Radiology. 2012 Jul;264(1):110-8. doi: 10.1148/radiol.12111623. Epub 2012 Apr 10.

PMID:
22495683
17.

Canadian Association of Radiologists Radiation Protection Working Group: review of radiation units and the use of computed tomography dose indicators in Canada.

Thakur Y, Bjarnason TA, Chakraborty S, Liu P, O'Malley ME, Coulden R, Noga M, Mason A, Mayo J.

Can Assoc Radiol J. 2013 Aug;64(3):166-9. doi: 10.1016/j.carj.2011.12.012. Epub 2012 Mar 10. Review. No abstract available.

18.

Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.

Choudry HA, Mavanur A, O'Malley ME, Zeh HJ, Guo Z, Bartlett DL.

Ann Surg Oncol. 2012 May;19(5):1402-9. doi: 10.1245/s10434-012-2242-5.

19.

Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer.

Sathaiah M, Thirunavukkarasu P, O'Malley ME, Kavanagh MA, Ravindranathan R, Austin F, Guo ZS, Bartlett DL.

Cancer Gene Ther. 2012 Mar;19(3):192-201. doi: 10.1038/cgt.2011.77. Epub 2011 Nov 25.

20.

Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth.

Li Q, O'Malley ME, Bartlett DL, Guo ZS.

Mol Cancer. 2011 May 24;10:63. doi: 10.1186/1476-4598-10-63.

21.

Lymph node growth rate in testicular germ cell tumours: implications for computed tomography surveillance frequency.

Mazrani W, O'Malley ME, Chung PW, Warde P, Vesprini D, Panzarella T.

Clin Oncol (R Coll Radiol). 2011 Jun;23(5):333-8. doi: 10.1016/j.clon.2010.10.006. Epub 2010 Nov 16.

PMID:
21084179
22.

The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.

Guo ZS, Parimi V, O'Malley ME, Thirunavukarasu P, Sathaiah M, Austin F, Bartlett DL.

Gene Ther. 2010 Dec;17(12):1465-75. doi: 10.1038/gt.2010.104. Epub 2010 Aug 12.

23.

TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer.

Ziauddin MF, Guo ZS, O'Malley ME, Austin F, Popovic PJ, Kavanagh MA, Li J, Sathaiah M, Thirunavukarasu P, Fang B, Lee YJ, Bartlett DL.

Gene Ther. 2010 Apr;17(4):550-9. doi: 10.1038/gt.2010.5. Epub 2010 Feb 25.

24.

Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance.

O'Malley ME, Chung P, Haider M, Jang HJ, Jhaveri K, Khalili K, Panzarella T, Warde P.

Eur Radiol. 2010 Jul;20(7):1624-30. doi: 10.1007/s00330-009-1710-1. Epub 2010 Jan 30.

PMID:
20119727
25.

Split-bolus MDCT urography: Upper tract opacification and performance for upper tract tumors in patients with hematuria.

Maheshwari E, O'Malley ME, Ghai S, Staunton M, Massey C.

AJR Am J Roentgenol. 2010 Feb;194(2):453-8. doi: 10.2214/AJR.09.3228.

PMID:
20093609
26.

Three epigenetic drugs up-regulate homeobox gene Rhox5 in cancer cells through overlapping and distinct molecular mechanisms.

Li Q, Bartlett DL, Gorry MC, O'Malley ME, Guo ZS.

Mol Pharmacol. 2009 Nov;76(5):1072-81. doi: 10.1124/mol.109.056291. Epub 2009 Aug 13.

PMID:
19679824
27.

Magnetic resonance imaging of the urinary bladder: cancer staging and beyond.

Haider EA, Jhaveri KS, O'Malley ME, Haider MA, Jewett MA, Rendon RA.

Can Assoc Radiol J. 2008 Dec;59(5):241-58. Review. No abstract available.

PMID:
19385152
28.

Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Chalikonda S, Kivlen MH, O'Malley ME, Eric Dong XD, McCart JA, Gorry MC, Yin XY, Brown CK, Zeh HJ 3rd, Guo ZS, Bartlett DL.

Cancer Gene Ther. 2008 Feb;15(2):115-25. Epub 2007 Dec 14.

29.

Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation.

Ghai S, Pattison J, Ghai S, O'Malley ME, Khalili K, Stephens M.

Radiographics. 2007 Sep-Oct;27(5):1371-88. Review.

PMID:
17848697
30.

Adverse events with universal use of iodixanol for CT: comparison with iohexol.

Ho AL, O'Malley ME, Tomlinson GA.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):165-8.

PMID:
17414747
31.
32.

A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.

Yang S, Guo ZS, O'Malley ME, Yin X, Zeh HJ, Bartlett DL.

Gene Ther. 2007 Apr;14(8):638-47. Epub 2007 Feb 1.

PMID:
17268533
33.
34.

Variability in size measurement of renal masses smaller than 4 cm on computerized tomography.

Punnen S, Haider MA, Lockwood G, Moulding F, O'Malley ME, Jewett MA.

J Urol. 2006 Dec;176(6 Pt 1):2386-90; discussion 2390.

PMID:
17085106
35.

Imaging of hepatic infections.

Doyle DJ, Hanbidge AE, O'Malley ME.

Clin Radiol. 2006 Sep;61(9):737-48. Review.

PMID:
16905380
36.

The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2.

Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL.

Cancer Res. 2005 Nov 1;65(21):9991-8.

37.
38.

Adrenal metastasis from ovarian carcinoma.

Patlas M, O'Malley ME, Chapman W.

AJR Am J Roentgenol. 2004 Dec;183(6):1711-2. No abstract available.

PMID:
15547215
39.

From the RSNA refresher courses: imaging evaluation for acute pain in the right upper quadrant.

Hanbidge AE, Buckler PM, O'Malley ME, Wilson SR.

Radiographics. 2004 Jul-Aug;24(4):1117-35. Review.

PMID:
15256633
40.

Triple-phase MDCT of hepatocellular carcinoma.

Lee KH, O'Malley ME, Haider MA, Hanbidge A.

AJR Am J Roentgenol. 2004 Mar;182(3):643-9.

PMID:
14975963
41.

Manually respiratory-triggered single-shot fast spin-echo: a non-breath-hold T2-weighted method for liver lesion detection.

O'Riordan E, Haider MA, O'Malley ME, Khalili K, Ibach K, Lockwood GA, Bahadorani B.

Can Assoc Radiol J. 2003 Dec;54(5):289-95; quiz 270-1.

PMID:
14689803
42.

Portal vein gas resulting from ingestion of hydrogen peroxide.

Ghai S, O'Malley ME.

AJR Am J Roentgenol. 2003 Dec;181(6):1719-20. No abstract available.

PMID:
14627607
43.

Comparison of excretory phase, helical computed tomography with intravenous urography in patients with painless haematuria.

O'Malley ME, Hahn PF, Yoder IC, Gazelle GS, McGovern FJ, Mueller PR.

Clin Radiol. 2003 Apr;58(4):294-300.

PMID:
12662950
44.

Pictorial essay. Hepatocellular carcinoma: imaging and imaging-guided intervention.

Lee KH, O'Malley ME, Kachura JR, Haider M, Hanbidge A.

AJR Am J Roentgenol. 2003 Apr;180(4):1015-22. No abstract available.

PMID:
12646447
45.

US of gastrointestinal tract abnormalities with CT correlation.

O'Malley ME, Wilson SR.

Radiographics. 2003 Jan-Feb;23(1):59-72. Review.

PMID:
12533641
46.

Herpes vector-mediated expression of proenkephalin reduces bone cancer pain.

Goss JR, Harley CF, Mata M, O'Malley ME, Goins WF, Hu X, Glorioso JC, Fink DJ.

Ann Neurol. 2002 Nov;52(5):662-5.

PMID:
12402268
47.

Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better?

Haider MA, Amitai MM, Rappaport DC, O'Malley ME, Hanbidge AE, Redston M, Lockwood GA, Gallinger S.

Radiology. 2002 Oct;225(1):137-42.

PMID:
12354997
48.

Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results.

Sahani DV, O'Malley ME, Bhat S, Hahn PF, Saini S.

J Comput Assist Tomogr. 2002 Mar-Apr;26(2):216-22.

PMID:
11884777
49.
50.

Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial.

Sherar MD, Gertner MR, Yue CK, O'Malley ME, Toi A, Gladman AS, Davidson SR, Trachtenberg J.

J Urol. 2001 Nov;166(5):1707-14.

PMID:
11586207

Supplemental Content

Loading ...
Support Center